Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice.

Science advances·2026

Same author

Pathophysiology, biological models and new therapeutic approaches in β-Propeller Associated Neurodegeneration.

International review of cell and molecular biology·2026

Same author

Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia.

Orphanet journal of rare diseases·2025

Same author

Mitochondrial Unfolded Protein Response (mtUPR) Activation Improves Pathological Alterations in Cellular Models of Ethylmalonic Encephalopathy.

Antioxidants (Basel, Switzerland)·2025

Same author

Polydatin and Nicotinamide Prevent Iron Accumulation and Lipid Peroxidation in Cellular Models of Mitochondrial Diseases.

Antioxidants (Basel, Switzerland)·2025

Same author

Iron Accumulation and Lipid Peroxidation in Cellular Models of Nemaline Myopathies.

International journal of molecular sciences·2025

Search research articles

Related Experiment Video

Updated: Nov 30, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Precision Medicine in Rare Diseases.

Irene Villalón-García¹, Mónica Álvarez-Córdoba¹, Juan Miguel Suárez-Rivero¹

¹Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III, 41013 Sevilla, Spain.

Diseases (Basel, Switzerland)

|November 18, 2020

Summary

Patients with rare diseases often face long diagnostic journeys. This research proposes using personalized medicine and patient cells for drug screening to find effective rare disease treatments.

Keywords:

congenital myopathies mitochondrial diseases neurodegeneration with brain iron accumulation precision medicine rare diseases

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Related Experiment Videos

Last Updated: Nov 30, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Area of Science:

Genetics
Pharmacology
Rare Diseases

Background:

Rare diseases affect 7% of the global population, with over 7000 identified types.
Patients frequently experience a 'diagnostic odyssey' due to the complexity of rare conditions.
A significant challenge is the lack of effective treatments for over 90% of rare diseases.

Purpose of the Study:

To explore precision medicine as a strategy for identifying rare disease therapies.
To propose a novel approach using patient-derived cells for personalized drug screening.

Main Methods:

Utilizing patient-derived cells for in vitro studies.
Implementing personalized pharmacological screening techniques.

Main Results:

The study proposes a method for personalized drug screening using patient cells.
This approach aims to identify potential therapies for rare diseases.

Conclusions:

Precision medicine offers a promising avenue for tackling the therapeutic challenges in rare diseases.
Personalized pharmacological screening with patient cells could accelerate the discovery of effective treatments.